Hernia Class Action Lawsuit: MDL, Bard Settlement, Eligibility

There is no traditional hernia mesh class action lawsuit. The cases are organized as multidistrict litigation, or MDL, where each patient files a separate lawsuit and keeps their own attorney, but the cases are grouped before a single federal judge for pretrial work. More than 26,000 cases were pending across several federal MDLs as of mid-2026, and the largest financial resolution to date is Becton Dickinson’s roughly $1.7 billion settlement announced in October 2024 to resolve the bulk of claims against its subsidiary C.R. Bard.

Why It’s an MDL, Not a Class Action

The distinction matters for anyone trying to figure out whether to “join” something. In a class action, one lawsuit represents the whole group, a single verdict or settlement applies to everyone, and compensation gets divided among class members. In an MDL, each plaintiff has their own case. The cases are simply gathered before one judge so that shared pretrial work — document discovery, expert testimony, procedural rulings — doesn’t have to be repeated thousands of times. When pretrial ends, unresolved cases can be sent back to their home courts for individual trials.

Hernia mesh cases are structured this way because the injuries vary too much to lump together. One patient may have needed emergency surgery after mesh migrated into the bowel; another may have lived with chronic groin pain for years before a diagnosis. The MDL format lets courts resolve common legal questions once while still tailoring compensation to each plaintiff’s specific harm.

The Bard Settlement

On October 2, 2024, Becton Dickinson announced it had reached an agreement to resolve the “vast majority” of Bard hernia mesh claims. The deal covers roughly 25,000 cases in the federal MDL (In re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation, MDL 2846, before Judge Edmund A. Sargus Jr. in the Southern District of Ohio) and more than 15,000 cases in Rhode Island state courts. BD’s financial disclosures showed the company had accrued $1.7 billion for hernia product liability as of mid-2024.1Law.com. BD Settles Thousands of Bard Hernia Mesh Lawsuits

The settlement uses a three-tier structure:

  • Claimants with an implant but no qualifying injury can accept a $2,500 “Quick Pay” offer.
  • Those with mild-to-moderate complications and a single revision surgery can receive $25,000.
  • Plaintiffs with severe injuries, including multiple surgeries, permanent disability, or major organ damage, are eligible for payouts in the $60,000 to over $100,000 range through a “Traditional Pay” track. Amounts are determined by a points-based matrix accounting for injury severity, medical documentation, and the specific Bard product involved.

Average gross payouts across all tiers are projected at $65,000 to $70,000 per claimant, though net amounts after attorney fees and lien deductions are typically 40 to 50 percent lower.2Talli AI. C.R. Bard Hernia Mesh Settlement

A Qualified Settlement Fund was established in January 2025, administered by Orion Settlement Solutions and held in escrow at Wells Fargo. In November 2025, Judge Sargus appointed two special masters to oversee an Intensive Settlement Process scheduled to launch in January 2027 for unresolved claims. Claimants who are unsatisfied with their offers have until June 2029 to opt out and return to active litigation.3Llamalab. Bard Hernia Mesh Settlement Medical Records Payout Tiers4Motley Rice LLC. Hernia Mesh Roughly 23,700 Bard cases still remained on the MDL docket in early 2026 as the settlement process worked through claims.5JPML. Pending MDL Dockets by Actions Pending The products at issue include the Ventralex, PerFix Plug, 3DMax, Composix, Sepramesh, and Kugel lines.6Shouse Law Group. C.R. Bard Hernia Mesh Products

Where the Other Manufacturers Stand

If your mesh wasn’t a Bard product, the Bard settlement doesn’t apply to you. Three other federal MDLs cover different manufacturers, each at a different stage.

Covidien / Medtronic

In re: Covidien Hernia Mesh Products Liability Litigation (No. II) (MDL 3029) is centralized in the District of Massachusetts under Judge Patti B. Saris, with roughly 2,400 cases pending as of mid-2026.7MDL Update. Covidien Hernia Mesh MDL 3029 The products at issue are polyester-based: primarily Parietex Composite, Parietex ProGrip, and Symbotex Composite, manufactured by Covidien (acquired by Medtronic in 2015). Plaintiffs allege the polyester causes inflammation and mechanical failures such as breakage and fragmentation.8JPML. MDL 3029 Initial Transfer Order

This is the most active litigation front in 2026. The first bellwether case, Patterson v. Covidien, involves a plaintiff who alleges a defective Symbotex mesh caused a bowel blockage in 2020. After Covidien’s summary judgment motion was largely denied, a Massachusetts federal judge ruled in June 2026 that a reasonable jury could find the company failed to adequately warn physicians about certain risks, clearing the way for trial.9Law360. Medtronic Unit Must Face Bellwether Hernia Mesh Claims10GovInfo. Patterson v. Covidien, Memorandum and Order A second bellwether trial, involving a Mississippi plaintiff, is also scheduled for July 2026. No global settlement has been reached, though mediation discussions are ongoing.11Levin Law. Hernia Mesh Lawsuit

Atrium Medical

Roughly 300 to 400 cases remain in In re: Atrium Medical Corp. C-Qur Mesh Products Liability Litigation (MDL 2753) in the District of New Hampshire.5JPML. Pending MDL Dockets by Actions Pending The C-Qur line used a fish oil coating that plaintiffs allege increased the risk of adhesion and infection. In late 2021, Atrium’s parent company, Getinge Group, reportedly allocated $66 million for a settlement fund.12Drugwatch. Hernia Mesh Settlements A court-approved settlement process is now underway. A special master values each claim using a points-based matrix that weighs the type of product, the specific injuries, and the medical treatment received. The deal requires 95 percent of plaintiffs in the MDL to opt in or the defendants can walk away. Judge McCafferty has stayed all proceedings while the settlement process plays out.13Stagliuzza Law. Atrium Hernia Mesh Lawsuit Update

Ethicon / Johnson & Johnson

Ethicon’s Physiomesh was withdrawn from the global market in May 2016 after studies in Germany and Denmark showed higher rates of hernia recurrence and reoperation compared to competing devices.14Seeger Weiss LLP. Physiomesh Lawsuit The MDL in the Northern District of Georgia once included thousands of cases but has largely wound down through confidential settlements. Ethicon resolved more than 3,700 cases organized across New Jersey and Georgia courts in September 2021, settled another 292 claims in May 2023, and resolved more than 200 remaining cases in late 2023.15MedTech Dive. J&J Hernia Mesh Settlement Prompts Judge to Dismiss More Than 200 Cases As of early 2025, only about 14 plaintiffs remained in the federal MDL.4Motley Rice LLC. Hernia Mesh For practical purposes, the window to file a new Physiomesh claim in this MDL has closed.

Other Manufacturers

LifeCell Corporation faces lawsuits over its Strattice Reconstructive Tissue Matrix, a porcine-derived biologic mesh, with cases consolidated in the District of New Jersey. A March 2024 New Jersey state trial cleared LifeCell of liability in Blakely v. LifeCell Corp., though the plaintiff has announced plans to appeal. Federal bellwether trials were scheduled for 2026.16The Indiana Lawyer. LifeCell Not Liable, Jurors Rule in Strattice Mesh Hernia Lawsuit17NeuralIT. First Federal Bellwether Trial Set in Strattice Mesh Case W.L. Gore & Associates has also been named in lawsuits over its Gore-Tex and DualMesh products, though those cases have not been consolidated into a federal MDL.18ConsumerNotice. Hernia Mesh Lawsuit Settlements

Injuries That Support a Claim

The lawsuits center on a consistent set of complications after mesh implantation. The most commonly alleged injuries include:

  • Chronic pain lasting months or years, sometimes caused by nerve damage or ongoing inflammation. One estimate cited in litigation holds that roughly one in three hernia mesh patients experiences chronic pain.
  • Mesh migration away from the surgical site, potentially damaging surrounding organs or tissue.
  • Adhesion, where the mesh bonds to organs or tissue it was never intended to contact.
  • Bowel obstruction when mesh adheres to or penetrates the intestines.
  • Infection and chronic inflammation around the implant.
  • Hernia recurrence because the mesh failed, shrank, or folded.
  • Organ perforation from migrating mesh.

Revision surgery, often more than one operation, is typically needed to remove or replace faulty mesh, and the need for revision surgery is usually a threshold requirement for filing a claim.19Drugwatch. Hernia Mesh Lawsuits20ConsumerNotice. Hernia Mesh Lawsuits

Eligibility and Deadlines

General eligibility criteria require that the patient underwent a hernia repair using mesh, experienced serious complications that manifested more than 30 days after the original surgery, and needed at least one revision surgery to address mesh-related problems.20ConsumerNotice. Hernia Mesh Lawsuits Qualifying surgery dates vary by manufacturer, with some proceedings covering implantations as far back as January 2006. Statutes of limitations typically run two to three years from the date the injury was discovered, though the specific deadline depends on the state where the claim is filed.

Legal theories in these cases generally rest on three pillars: defective product design, manufacturing defects, and failure to warn patients and physicians about known risks. Bellwether trials in the Bard MDL have tested all three, and outcomes have turned on which theory the jury accepts. In the Stinson trial, for instance, the jury found Bard liable for failure to warn but not for design defect.21Seeger Weiss LLP. Seeger Weiss Helps Secure $500,000 Jury Verdict in Bard Hernia Mesh Bellwether Trial Because each case is evaluated individually within the MDL structure, the specific mesh product, the severity of complications, and the quality of medical documentation all directly affect the potential outcome.

A Note on Class Actions Outside the U.S.

True class actions do exist, but in Canada rather than the United States. The law firm Siskinds LLP has filed proposed class actions in Ontario against Bard, Atrium, and Covidien, all progressing toward certification hearings. A separate Canadian class action against Ethicon over Physiomesh was discontinued in April 2024 after the parties agreed to implement a settlement program for identified class members.22Siskinds LLP. Physiomesh Hernia Mesh For patients in the United States, the path to compensation runs through an individual lawsuit filed into one of the MDLs, not a class action.